An Open Label, Single Dose, Microdialysis and Pharmacokinetic Study of TR-701 [DA 7218] in Normal Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Tedizolid (Primary)
- Indications Gram-positive infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Trius Therapeutics
- 12 Oct 2011 Actual end date (March 2009) added as reported by ClinicalTrials.gov.
- 12 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2008 New trial record.